Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 190.75-6.18-66.140.2217.80

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is 190.75 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025190.75
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 190.75
Positive
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,961.3 Cr 0.7% 5.4% 29.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.2% 1.1% -0.4% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr 0.7% -2.9% 6.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -1.6% 13.6% Stock Analytics
CIPLA ₹120,919.0 Cr 0.7% -2.4% 4.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr 2.2% 2.8% 2.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.7%

5.4%

29.4%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses